Skip to content

Three Quick Facts: Nightcap, Belluscura and Vela Technologies


Here are three things you need to know in the financial markets this morning from investment writer, Tony Cross.

#1. Nightcap signs lease on a new property in the City of London

It’s another quiet day in terms of pre-market regulatory filings but we do have an announcement from Nightcap LON:NGHT, the AIM listed bar operator, that it has signed a lease on a new property in the City of London. It expects to open the venue before the year end, offering some insight from the firm as to how it thinks the market will continue growing into the Winter. The note adds that negotiations are currently ongoing over a further five sites.

#2. Belluscura expects pandemic to increase demand for oxygen therapies

Sticking with AIM, Belluscura LON:BELL, the manufacturer of portable oxygen generators whose shares debuted back in May, has published its half year report this morning. The company believes that the long term health impacts of the COVID-19 pandemic will increase demand for oxygen therapies and accelerate market growth. Distribution of its first units only started last week, so the balance sheet is still very much pre-revenue but this could be a firm that is very much responding to the needs of the day.

#3. Vela Technologies pushes back trial results

Finally, a quick update from Vela Technologies LON:VELA over trials being conducted for diabetic patients suffering from COVID-19. It had previously expected to report results here by today, but the note advises that these findings have been pushed back to no later than Friday September 10th.

Looking for great investing ideas? Sign up to our free newsletter.

This article does not constitute investment advice. Make sure you do your own research or consult a professional advisor.

'How to' Guides

Our latest in-depth company reports

Detailed reviews of selected companies and investment trusts.

On the podcast

Sign up for great investing stock tips

Thanks to our Site Partners

Our partners are established, regulated businesses and we are grateful for their support.

CME Group
FP Markets
Back To Top